Research & Development Scientist, Thermo Fisher ScientificBiography
Dr. Bramlett leads the RNA Sequencing Applications Team at Life Sciences Solutions, Thermo Fisher Scientific. She guides the Research & Development effort focused on creating innovative sequencing and data analysis solutions for the detailed analysis of RNA. Prior to joining Thermo Fisher Scientific, Dr. Bramlett was a drug development scientist at Eli Lilly and Company, where she led a team of scientists specializing in gene regulation and nuclear receptor biology to identify novel drug targets. Dr. Bramlett built her background and experience in gene regulation through prior academic positions at Baylor College of Medicine and the M.D. Anderson Cancer Center. Kelli holds an undergraduate degree in Chemistry from Rice University in Houston, Texas, and a masters degree in Pharmacology from the Indiana University School of Medicine in Indianapolis, Indiana.